Publications
Review & Commentary
Role of autoantibodies in type 1 diabetes
(2007). Front Biosci, 12 (0), 1889-1898. , PMID: 17127428
Miao D, Yu L, Eisenbarth GS
[Reprint] [PubMed]
[Citation View]
Miao D, Yu L, Eisenbarth GS (2007). Role of autoantibodies in type 1 diabetes. Front Biosci, 12 (0), 1889-1898.
Interferon alpha--a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity
(2004). Clin Immunol, 111 (3), 225-33. , PMID: 15183143
Devendra D, Eisenbarth GS
[Reprint] [PubMed]
[Citation View]
Devendra D, Eisenbarth GS (2004). Interferon alpha--a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin Immunol, 111 (3), 225-33.
Type 1 diabetes: recent developments
(2004). BMJ, 328 (7442), 750-754. , PMID: 15044291, PMCID: PMC381328
Devendra D, Liu E, Eisenbarth GS
[Reprint] [PubMed]
[Citation View]
Devendra D, Liu E, Eisenbarth GS (2004). Type 1 diabetes: recent developments. BMJ, 328 (7442), 750-754.
Autoimmune polyendocrine syndromes
(2004). New Engl J Med, 350 (20), 36-47. , PMID: 15141045
Eisenbarth GS, Gottlieb PA
[Reprint] [PubMed]
[Citation View]
Eisenbarth GS, Gottlieb PA (2004). Autoimmune polyendocrine syndromes. New Engl J Med, 350 (20), 36-47.
Disease prevention with islet autoantigens
(2004). Endocrinol Metab Clin North Am, 33 (1), 59-74. , PMID: 15053895
Eisenbarth G, Jasinski J
[Reprint] [PubMed]
[Citation View]
Eisenbarth G, Jasinski J (2004). Disease prevention with islet autoantigens. Endocrinol Metab Clin North Am, 33 (1), 59-74.
What impact will the Immune Tolerance Network have on the future treatment of allergic diseases?
(2004). Clin Exp Allergy, 34 (11), 1657-1659. , PMID: 15544586
Saxon, A
[Reprint] [PubMed]
[Citation View]
Saxon, A (2004). What impact will the Immune Tolerance Network have on the future treatment of allergic diseases?. Clin Exp Allergy, 34 (11), 1657-1659.
Clinical trials of transplant tolerance: slow but steady progress
(2003). Am J Transplant, 3 (7), 794-803. , PMID: 12814471
Matthews JB, Ramos E, Bluestone JA
[Reprint] [PubMed]
[Citation View]
Matthews JB, Ramos E, Bluestone JA (2003). Clinical trials of transplant tolerance: slow but steady progress. Am J Transplant, 3 (7), 794-803.
MHC multimers: expanding the clinical toolkit
(2003). Clin Immunol, 106 (1), 1-4. , PMID: 12584043
Nepom, GT
[Reprint] [PubMed]
[Citation View]
Nepom, GT (2003). MHC multimers: expanding the clinical toolkit. Clin Immunol, 106 (1), 1-4.
The Immune Tolerance Network: a new paradigm for developing tolerance-inducing therapies
(2002). J Allergy Clin Immunol, 110 (1), 17-23. , PMID: 12110811
Rotrosen D, Matthews JB, Bluestone JA
[Reprint] [PubMed]
[Citation View]
Rotrosen D, Matthews JB, Bluestone JA (2002). The Immune Tolerance Network: a new paradigm for developing tolerance-inducing therapies. J Allergy Clin Immunol, 110 (1), 17-23.
The Immune Tolerance Network: tolerance at the crossroads
(2001). Philos Trans R Soc Lond B Biol Sci, 356 (1409), 773-6. , PMID: 11375080, PMCID: PMC1088464
Bluestone JA, Matthews J
[Reprint] [PubMed]
[Citation View]
Bluestone JA, Matthews J (2001). The Immune Tolerance Network: tolerance at the crossroads. Philos Trans R Soc Lond B Biol Sci, 356 (1409), 773-6.
The Immune Tolerance Network and rheumatic disease: immune tolerance comes to the clinic
(2001). Arthritis Rheum, 44 (8), 1730-5. , PMID: 11508422
Diamond B, Bluestone J, Wofsy D
[Reprint] [PubMed]
[Citation View]
Diamond B, Bluestone J, Wofsy D (2001). The Immune Tolerance Network and rheumatic disease: immune tolerance comes to the clinic. Arthritis Rheum, 44 (8), 1730-5.
The Immune Tolerance Network--an NIH/JDF-supported initiative to bring tolerance research into the clinic: a major new resource for clinical immunologists
(2000). Clin Immunol, 96 (3), 171-3. , PMID: 10964534
Bluestone JA, Matthews JB
[Reprint] [PubMed]
[Citation View]
Bluestone JA, Matthews JB (2000). The Immune Tolerance Network--an NIH/JDF-supported initiative to bring tolerance research into the clinic: a major new resource for clinical immunologists. Clin Immunol, 96 (3), 171-3.